Literature DB >> 23813802

Analysis of 16,192 anterior cruciate ligament reconstructions from a community-based registry.

Gregory B Maletis1, Maria C S Inacio, Tadashi T Funahashi.   

Abstract

BACKGROUND: Orthopaedic registries have shown value in tracking and surveillance of patients, implants, and outcomes associated with procedures. No current anterior cruciate ligament reconstruction registry (ACLRR) exists in the United States.
PURPOSE: To describe the current cohort captured by an institutional ACLRR and describe the outcomes observed in the registered patients and how findings from the ACLRR are disseminated. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: The anterior cruciate ligament reconstructions (ACLRs) registered between February 2005 and September 2011 by 244 surgeons in 48 medical centers were evaluated. The ACLRR collected data intra- and postoperatively using paper forms and electronic medical records. The ACLRR cohort was longitudinally followed and outcomes were prospectively ascertained. Outcomes (ie, revisions, subsequent operations, venous thromboembolism, and surgical site infections) were adjudicated via chart review. Descriptive statistics are used to describe the cohort and Kaplan-Meier curves to evaluate survival.
RESULTS: During the study period, 16,192 ACLRs (15,101 primary and 1091 revisions) with a median follow-up of 1.6 years (interquartile range, 0.7-2.8 years) were registered. Male patients received 64% of both primary and revision ACLRs. The mean age at surgery was 29.5 years (SD, 11.4 years) for primary and revision reconstructions. Cartilage injuries were noted in 25.2% of primary and 37.5% of revision ACLRs, and meniscal injuries were identified in 60.8% and 53.2%, respectively. Autografts were used in 57.6% of primary ACLRs and 20.9% of revisions. Allografts were used in 42.4% of primaries and 78.8% of revisions. In primary ACLR, the most common femoral and tibial fixation types were interference screws (42.2% and 79.7%, respectively). Fixation type distribution was nearly identical in primaries and revisions. Of the primary ACLRs, 3.7% had subsequent operations on the same knee and 1.7% on the contralateral knee. Deep surgical site infection developed in 0.3% of primaries and 0.8% of revisions. Symptomatic deep vein thromboses were seen in 0.2% of both primaries and revisions. The overall revision rate was 1.7%. Lower rates of graft survival were identified in younger patients and those with allografts.
CONCLUSION: Large, community-based ACLRRs are useful in informing participating surgeons of current treatment practices, prevalence of concurrent injuries, and outcomes associated with the procedures. Information from the ACLRR can be used to develop interactive patient and surgeon tools that can be used to optimize patient care.

Entities:  

Keywords:  ACL reconstruction registry; anterior cruciate ligament reconstruction; graft; ligament registry

Mesh:

Year:  2013        PMID: 23813802     DOI: 10.1177/0363546513493589

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  33 in total

1.  Predictors for additional anterior cruciate ligament reconstruction: data from the Swedish national ACL register.

Authors:  Anne Fältström; Martin Hägglund; Henrik Magnusson; Magnus Forssblad; Joanna Kvist
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-01       Impact factor: 4.342

2.  Comparison of clinical outcomes and second-look arthroscopic findings after ACL reconstruction using a hamstring autograft or a tibialis allograft.

Authors:  Seung-Hyun Yoo; Eun-Kyoo Song; Young-Rok Shin; Sung-Kyu Kim; Jong-Keun Seon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-30       Impact factor: 4.342

3.  ACL Study Group survey reveals the evolution of anterior cruciate ligament reconstruction graft choice over the past three decades.

Authors:  Markus P Arnold; Jacob G Calcei; Nicole Vogel; Robert A Magnussen; Mark Clatworthy; Tim Spalding; John D Campbell; John A Bergfeld; Seth L Sherman
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-01-24       Impact factor: 4.342

Review 4.  Revision anterior cruciate ligament reconstruction: clinical outcome and evidence for return to sport.

Authors:  Luca Andriolo; Giuseppe Filardo; Elizaveta Kon; Margherita Ricci; Francesco Della Villa; Stefano Della Villa; Stefano Zaffagnini; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-07-23       Impact factor: 4.342

5.  Femoral-tibial fixation affects risk of revision and reoperation after anterior cruciate ligament reconstruction using hamstring autograft.

Authors:  Lindsey M Spragg; Heather A Prentice; Andrew Morris; Tadashi T Funahashi; Gregory B Maletis; Rick P Csintalan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-03-01       Impact factor: 4.342

6.  Medial collateral ligament (MCL) reconstruction results in improved medial stability: results from the Danish knee ligament reconstruction registry (DKRR).

Authors:  Martin Lind; Kevin Jacobsen; Torsten Nielsen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-05-23       Impact factor: 4.342

Review 7.  The role of anterolateral augmentation in primary ACL reconstruction.

Authors:  David Ferguson; Rory Cuthbert; Saket Tibrewal
Journal:  J Clin Orthop Trauma       Date:  2019-10-07

8.  Incidence of Second Anterior Cruciate Ligament Tears (1990-2000) and Associated Factors in a Specific Geographic Locale.

Authors:  Nathan D Schilaty; Nathaniel A Bates; Thomas L Sanders; Aaron J Krych; Michael J Stuart; Timothy E Hewett
Journal:  Am J Sports Med       Date:  2017-03-01       Impact factor: 6.202

Review 9.  Outcomes Following ACL Reconstruction Based on Graft Type: Are all Grafts Equivalent?

Authors:  Matthew Widner; Mark Dunleavy; Scott Lynch
Journal:  Curr Rev Musculoskelet Med       Date:  2019-12

10.  No negative effect on patient-reported outcome of concomitant cartilage lesions 5-9 years after ACL reconstruction.

Authors:  Svend Ulstein; Karin Bredland; Asbjørn Årøen; Lars Engebretsen; Jan Harald Røtterud
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-19       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.